Abstract
Introduction
Pathogenic bacteria pose a major threaten to public health, especially in under-developed region of the world. Large scale production and use of antibiotic penicillin during the World War II is a hallmark of modern antimicrobial therapy. Since then, a plethora of antimicrobial agents have been developed and commercialized, playing significant roles in improvement of human health, highlighted by gradual increasing of average life span worldwide. Prevailing of antibiotic treatment improves human health on one hand, but also triggers resistance of microbes to the drugs [1, 2] .
Depending on their structures and target sites within microorganism, different antibacterial drugs have distinct modes of action [3] . Of them, related to cell membrane are: inhibition or block of cell wall synthesis, inhibition of membrane protein or lipid synthesis and interference of cell membrane function. Some antibacterial peptides [4, 5] , peptidomimics [6] and small proteins [7] could interact with or insert into cell membrane, where they interfere membrane formation or alter local membrane structure, thus reducing bacteria growth or reproduction. Bacterial membrane is surrounded by a layer of peptidoglycan cell wall. This unique feature had rendered great interest in searching for glycopeptide and lipoglycopeptide [8] , which mimics bacterial cell wall synthesis substrates or binds to synthesis intermediates, thus inhibits cell wall synthesis, while having little effect on host cells.
Glycopeptide antibiotic vancomycin has been used to treat a number of infections caused by broad spectrum of gram-positive bacteria [9, 10] . It inhibits cell wall formation by binding to D-Ala-D-Ala terminus of peptidoglycan precursors and preventing them from cross-linking [11, 12] . To cope with rising of antibiotic resistance including vancomycin, development of novel anti-bacterial agents with multiple action modes had been a promising strategy [13] [14] [15] . Herein, we studied the binding property of vancomycin to artificial and bacterial membranes using different biophysics methods with the aim to obtain a better understanding of the binding process for expanding its antibiotic repository.
Experimental

Materials
-sn-glycero-3-phosphocholine (NBD PC) and cardiolipin (CL) were purchased from Avanti Polar Lipids. Vancomycin and nafcillin were obtained from Sigma. Lysozyme and RNaseA were purchased from Merck. Staphylococcus aureus was from ATCC (strain #43300) and cultured in tryptic soy broth medium (Becton, Dickinson and Company). Other chemicals were obtained from Sigma.
Liposome preparation
Lipids of known mass in chloroform were well-mixed, then dried at room temperature in a glass tube by continuous purging of high pure nitrogen gas. Being thoroughly dried in a speed vacuum, the lipids were redissolved in phosphate buffer saline (PBS) buffer (10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 137 mM NaCl, 2.7 mM KCl, pH 7.4) pre-warmed over 45 °C. After repeated pipetting, the hydrated lipids were applied to a Lipex extruder (Northern Lipids Inc.) equipped with polycarbonate membrane for more than 10 times. Scattering profile of the liposome was then measured on a BI-200SM goniometer (Brookhaven Instruments) while being excited by a laser passing 637 nm filter with 100 micron pinhole from 90 degree angle at 25 °C. Data was collected and processed by the dynamic light scatter software coming with the equipment.
Isolation of membrane from Staphylococcus aureus
Isolation of membrane was carried out as described in the literature [16] . Briefly, bacteria were cultured till late exponential phase before harvest. Cells was then re-suspended in 50 mM potassium phosphate buffer, pH 8.0 and digested by lysozyme, deoxyribonuclease-1 and ribonuclease for 30 minutes in the presence of 10 mM MgSO 4 at 37 °C. The reaction was stopped abruptly by 15 mM EDTA for 1 minute. Additional MgSO 4 was then added to the system to bring its final concentration back to 10 mM. Digested cells was centrifuged at room temperature, 25000 g for 45 minutes to pellet the membrane, which was then re-suspended in PBS and applied through 18-g needle for more than 20 times. Resultant membrane vesicle was quantified by measuring protein concentration (Pierce™ BCA protein assay, Thermo Scientific), assuming equivalent amount of protein and lipid. Size distribution of the vesicles was assessed on a BI-200SM goniometer as describe in previous section.
Isothermal calorimetry measurement
In a typical isothermal calorimetry (ITC) experiment carried out on a MicroCal iTC200 calorimeter (Malvern Instruments), 50 mM antibiotics were titrated into liposome with 5 mM lipid (total or individual) in PBS buffer at 25 °C. After each injection, system was allowed to regain thermal balance between sample and reference chambers for 180 seconds with continuous stir of 750 rpm. Acquired data were processed by ITC-costumed Origin7 software using one-site model to avoid complication. Reference subtractions were performed against the data obtained by titrating antibiotic into PBS buffer.
Fluorescence spectroscopy
Spectra of the fluorescent lipid incorporated liposome were collected on an LS55 Fluorescence spectrometer (PerkinElmer) at room temperature. Fluorescent spectra of freshly prepares 2-4 mM liposome containing 0.5 % NDB PC in PBS buffer was recorded in a cuvette. The sample was excited by xenon lamp centred at 485 nm with 2.5 nm slit width. A fraction of antibiotics with high concentration in PBS buffer was then introduced to minimize volume change. After mixed well, the spectrum of the sample was measured with the same setting.
Results
Vancomycin binds to liposome with a millimolar affinity.
We first utilized liposome as membrane mimic to explore if vancomycin associates with the cell membrane at all. We performed isothermal calorimetry experiment by titrating antibiotics into liposome extruded through polycarbonate membrane (0.1 µm diameter). We found that vancomycin, but not β-lactam antibiotic nafcillin, introduced significant amount of heat change in liposome prepared from a mixture of POPE, POPG and cardiolipin (CL) (75:20:5) (Figure 1) , a model mimic for bacterial membrane [17] . Fitting of the data into one-site model gave rise to millimolar level affinity (dissociate constant, K d ), suggesting that vancomycin weakly, but definitely interact with liposome. The observation is in line with previous studies, where weak binding of vancomycin to model membrane were assessed by ITC [18] and surface plasmon resonance [19] . 
Vancomycin binds to vesicle derived from Staphylococcus aureus membrane.
Now that we showed vancomycin association with membrane mimic liposome, it is tempting to ask whether the antibiotic can also bind to vesicle derived from biological sample. We thus isolated membrane from gram-positive bacterium Staphylococcus aureus by means of enzymatic digestion, mechanical disruption and syringe needle homogenization [16] . Resultant vesicle was then undergone calorimetric titration with vancomycin as the titrant. According to the fitting result of ITC data, vancomycin also bound to the bacterial derived vesicle (Figure 2 ), but with much higher affinity (sub-millimolar) than that of liposome (Figure 2 ). Although we cannot completely rule out the possibility of residual peptidoglycan remaining on the membrane, lysozyme digestion step of the cells should remove most, if not all of them. Apparently, vancomycin binds to the bacterial membrane derived vesicle with higher affinity. 
Vancomycin strengthens the association with liposome as its size increases.
In light of differential binding between liposome and membrane-derived vesicle to vancomycin and the fact that the later measured much larger in diameter than the former (Figure 2) , we speculated that the size of liposome/vesicle might play a role in the antibiotic association with membrane mimic. To test the hypothesis, we performed serial calorimetric titration of vancomycin into liposome prepared with polycarbonate membranes of various sizes (0.1, 0.4 and 1 µm). We found that the binding affinity of vancomycin increased along with liposome size increment. (Figure 3) , which indicated that cell surface landscape or/and membrane curvature could be an important factor in vancomycin association. 
Vancomycin binds preferentially to POPG over cardiolipin and POPE.
Because the lipids used in the study are similar structurally in fatty acid moiety but vary in head groups, we reasoned that their difference in head group could contribute differently to the association with vancomycin. To explore binding preference of vancomycin among lipids, we performed ITC measurement of the antibiotic with liposomes prepared from individual lipid. Based on the K a value derived from data fitting, binding affinity of vancomycin to POPG is significantly higher than that to POPE and CL (Figure 4) , suggesting that POPG is the major contributor to the association of vancomycin with liposome. The observation could be explained by careful examination of the structure of vancomycin [20, 21] and the lipids (Figure 4) . Positive charged amine in the head group of POPE does not appear to favour the interaction with uncharged vancomycin. Moreover, embedded hydroxyl group on hydrocarbon chain within two phosphoryl group is unlikely to facilitate binding in the case of cardiolipin. On the other hand, the two hydroxyls on the head group of the POPG could potentially interact with vancomycin via hydrogen bond formation, which promotes the glycopeptide association with lipid membrane [22] .
Vancomycin interaction with liposome does not involve acyl terminus of the lipids.
We have shown that vancomycin associates with liposome through its interaction with the head group of the lipids. But it remains unclear if the antibiotic could introduce any change inside the lipid bilayer. Fluorescence spectroscopy was performed to gain more insight into the binding of vancomycin to liposome. We incorporated trace amount (0.5 %) of tail fluorescence-labeled lipid (NDB-PC) into liposome. Addition of stoichiometric amount of vancomycin did not induce significant change in the spectrum of the liposome ( Figure 5 ), suggesting that binding of vancomycin to liposome might not involve the acyl terminus of the lipid. In other words, it is unlikely for the antibiotic to insert deep into the lipids bilayer. Otherwise, alteration in fluorescence intensity or/and peak position shift would be obvious because of fluorophore disturbing by the insertion, as seen in a control experiment, where pore formation by depsipeptide antibiotics, valinomycin [23, 24] reduced liposome fluorescence intensity substantially. This is consistent with the fact that vancomycin and other glycopeptides generally exhibit low membrane permeability [3, 22] . 
Discussion
We have shown that glycopeptide antibiotics vancomycin associate with biomimetic membrane, a fact have been largely ignored in the field because of its weak interaction [18, 19] . Furthermore, we showed for the first time that it binds to membrane vesicle derived from gram-positive bacteria Staphylococcus aureus in a similar fashion. These observations could potentially open a new avenue for the prototype antibiotics to tackle infectious microbes by blocking cell wall synthesis and interfering cell membrane function simultaneously. Multiple mechanism of action is thought to be an effective strategy to combat with prevalent resistance nowadays rising among pathological microorganism [14, 15, 25] . We also found that vancomycin appears to bind to the membrane from outside and the extent of association depends much on local phospholipid composition and the curvature of the membrane. POPG appears to be the favourite target for vancomycin binding. Moreover larger size (flattened surface) of the liposome enhances the binding. These findings could provide some design ideas for further modification of the antibiotics to optimize its binding to bacterial membrane, which may improve antibacterial potency. To this end, a further investigation of vancomycin structure and bacterial membrane composition is required. In addition, self [20, 21] and ligand-induced dimerization [26, 27] of vancomycin might also play an important role as a larger hydrophobic interface once shielded by dimeric interaction has to be covered by membrane association.
Conclusions
We have studied the binding of vancomycin to biomimetic membranes based on three phospholipid components and bacterial membranes by using a variety of biophysical methods, including isothermal calorimetry and fluorescence photometry. It has been shown that the ways of association of vancomycin to biomimetic membranes is very similar to that of vesicle derived from Staphylococcus aureus membrane. Our results clearly indicated that vancomycin associates to the cell membrane from outside, and does not permeate through the cell membrane, which is consistent with the mechanisms of the drug action. By varying the size and composition of the biomimetic membrane vesicles, it has been demonstrated that the extent of association depends on specific type of lipids and curvature of local membrane structure. These observations could potentially open a new avenue to revive the prototype antibiotic to fight infectious microbe through the design of specific tight binders to the outer surface of bacterial membranes to impede cell wall synthesis.
